Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

PBMCsec can help reduce and improve thick skin scars.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Some drugs may help treat both COVID-19 and radiation injury.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Anti-glycation treatments might slow skin aging, but more research is needed.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Finasteride effectively treats male hair loss, improving growth and density.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Antiandrogen therapy helps treat genetic hair loss.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Substances from dental stem cells might help treat hair loss.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.